Avalo Therapeutics, Inc. Share Price
NASDAQ: AVTX | Micro CapAvalo Therapeutics, Inc. Stock Performance
Avalo Therapeutics, Inc. Share Price Today
As of 30 October 2026, Avalo Therapeutics, Inc.'s share price is $7.45. The stock opened at $7.25, compared to its previous close of $7.12. During today's trading session, Avalo Therapeutics, Inc.'s share price traded between $7.19 and $7.70, with an average price of $7.44. Over the past 52 weeks, the stock has recorded a high of $24.23 and a low of $6.55. In terms of performance, Avalo Therapeutics, Inc.'s share price has declined by 44.48% over the last six months and is down 58.17% on a year-on-year basis.
Avalo Therapeutics, Inc. Share Price Chart
Avalo Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Avalo Therapeutics, Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
Avalo Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $15.38 | $7.46 | -51.40% |
Sep 2026 | $19.64 | $15.34 | -23.51% |
Aug 2026 | $18.07 | $20.05 | +9.89% |
Jul 2026 | $18.64 | $18.25 | -1.19% |
Jun 2026 | $15.90 | $18.47 | +15.94% |
May 2026 | $13.43 | $15.93 | +18.79% |
Apr 2026 | $15.10 | $13.41 | -10.72% |
Mar 2026 | $16.91 | $15.02 | -14.56% |
Feb 2026 | $15.78 | $17.58 | +16.23% |
Jan 2026 | $17.75 | $15.13 | -16.64% |
Dec 2025 | $18.50 | $18.14 | -4.85% |
Nov 2025 | $18.03 | $19.07 | +7.13% |